B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 720 KRW 1.51%
Market Cap: 481.3B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioNote Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Operating Income
-â‚©47B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Operating Income
â‚©369.6B
CAGR 3-Years
-22%
CAGR 5-Years
6%
CAGR 10-Years
9%
SK Bioscience Co Ltd
KRX:302440
Operating Income
-â‚©12B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Operating Income
â‚©156.5B
CAGR 3-Years
14%
CAGR 5-Years
19%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Operating Income
â‚©102.2B
CAGR 3-Years
31%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Operating Income
-â‚©5.7B
CAGR 3-Years
39%
CAGR 5-Years
11%
CAGR 10-Years
N/A
No Stocks Found

BioNote Inc
Glance View

Market Cap
481.7B KRW
Industry
Biotechnology

BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.

Intrinsic Value
4 394.57 KRW
Overvaluation 7%
Intrinsic Value
Price
B

See Also

What is BioNote Inc's Operating Income?
Operating Income
-47B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Operating Income amounts to -47B KRW.

Back to Top